AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 223 filers reported holding AMICUS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.56 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,619,901 | -12.8% | 2,518,084 | -9.9% | 0.01% | -14.3% |
| Q2 2023 | $35,119,279 | +65.7% | 2,796,121 | +46.3% | 0.01% | +40.0% |
| Q1 2023 | $21,190,007 | -7.8% | 1,910,731 | +1.5% | 0.01% | 0.0% |
| Q4 2022 | $22,986,887 | +9.3% | 1,882,628 | -6.6% | 0.01% | 0.0% |
| Q3 2022 | $21,039,000 | +42.7% | 2,015,296 | +46.8% | 0.01% | +66.7% |
| Q2 2022 | $14,740,000 | -15.3% | 1,372,470 | -25.3% | 0.00% | -25.0% |
| Q1 2022 | $17,405,000 | +0.7% | 1,837,835 | +22.8% | 0.00% | +33.3% |
| Q4 2021 | $17,289,000 | -14.9% | 1,496,850 | -29.7% | 0.00% | -25.0% |
| Q3 2021 | $20,320,000 | +5.2% | 2,127,755 | +6.2% | 0.00% | 0.0% |
| Q2 2021 | $19,311,000 | -19.7% | 2,003,212 | -17.7% | 0.00% | -33.3% |
| Q1 2021 | $24,053,000 | -65.8% | 2,434,552 | -20.0% | 0.01% | -66.7% |
| Q4 2020 | $70,284,000 | +96.2% | 3,043,906 | +20.0% | 0.02% | +80.0% |
| Q3 2020 | $35,830,000 | -11.4% | 2,537,538 | -5.4% | 0.01% | -16.7% |
| Q2 2020 | $40,461,000 | +31.5% | 2,683,089 | -19.5% | 0.01% | +9.1% |
| Q1 2020 | $30,780,000 | -6.3% | 3,331,187 | -1.2% | 0.01% | +37.5% |
| Q4 2019 | $32,852,000 | +73.2% | 3,372,952 | +42.6% | 0.01% | +60.0% |
| Q3 2019 | $18,970,000 | -35.5% | 2,365,335 | +0.4% | 0.01% | -37.5% |
| Q2 2019 | $29,408,000 | -11.8% | 2,356,397 | -3.8% | 0.01% | -20.0% |
| Q1 2019 | $33,328,000 | +102.5% | 2,450,582 | +42.6% | 0.01% | +100.0% |
| Q4 2018 | $16,461,000 | -15.8% | 1,718,190 | +6.2% | 0.01% | 0.0% |
| Q3 2018 | $19,558,000 | +14.6% | 1,617,664 | +48.0% | 0.01% | 0.0% |
| Q2 2018 | $17,069,000 | -16.6% | 1,092,777 | -19.7% | 0.01% | 0.0% |
| Q1 2018 | $20,476,000 | -32.7% | 1,361,441 | -35.6% | 0.01% | -28.6% |
| Q4 2017 | $30,407,000 | +1.9% | 2,113,032 | +6.7% | 0.01% | 0.0% |
| Q3 2017 | $29,853,000 | +208.2% | 1,979,650 | +105.8% | 0.01% | +250.0% |
| Q2 2017 | $9,687,000 | +74.8% | 961,906 | +23.8% | 0.00% | 0.0% |
| Q1 2017 | $5,541,000 | +51.6% | 777,146 | +5.7% | 0.00% | +100.0% |
| Q4 2016 | $3,655,000 | +31.8% | 735,435 | +96.2% | 0.00% | 0.0% |
| Q3 2016 | $2,773,000 | +77.6% | 374,769 | +31.2% | 0.00% | – |
| Q2 2016 | $1,561,000 | -85.6% | 285,687 | -77.7% | 0.00% | -100.0% |
| Q1 2016 | $10,841,000 | -29.4% | 1,282,834 | -18.9% | 0.00% | -25.0% |
| Q4 2015 | $15,346,000 | -9.0% | 1,581,994 | +31.3% | 0.00% | -33.3% |
| Q3 2015 | $16,860,000 | -5.3% | 1,205,114 | -4.2% | 0.01% | +20.0% |
| Q2 2015 | $17,803,000 | -1.0% | 1,258,149 | -23.9% | 0.01% | 0.0% |
| Q1 2015 | $17,990,000 | +92.2% | 1,653,433 | +47.0% | 0.01% | +66.7% |
| Q4 2014 | $9,360,000 | +1090.8% | 1,124,970 | +751.5% | 0.00% | – |
| Q3 2014 | $786,000 | +274.3% | 132,122 | +110.6% | 0.00% | – |
| Q2 2014 | $210,000 | +130.8% | 62,740 | +42.4% | 0.00% | – |
| Q1 2014 | $91,000 | -26.0% | 44,048 | -16.1% | 0.00% | – |
| Q4 2013 | $123,000 | -63.6% | 52,524 | -64.0% | 0.00% | – |
| Q3 2013 | $338,000 | -2.0% | 145,902 | -1.4% | 0.00% | – |
| Q2 2013 | $345,000 | -61.2% | 147,948 | -55.4% | 0.00% | – |
| Q4 2012 | $890,000 | +1136.1% | 331,769 | +2303.3% | 0.00% | – |
| Q3 2012 | $72,000 | -11.1% | 13,805 | -6.2% | 0.00% | – |
| Q2 2012 | $81,000 | – | 14,710 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |